Suboptimal prehospital decision- making for referral to alternative levels of care - frequency, measurement, acceptance rate and room for improvement.


Journal

BMC emergency medicine
ISSN: 1471-227X
Titre abrégé: BMC Emerg Med
Pays: England
ID NLM: 100968543

Informations de publication

Date de publication:
23 05 2022
Historique:
received: 20 12 2021
accepted: 05 05 2022
entrez: 23 5 2022
pubmed: 24 5 2022
medline: 26 5 2022
Statut: epublish

Résumé

The emergency medical services (EMS) have undergone dramatic changes during the past few decades. Increased utilisation, changes in care-seeking behaviour and competence among EMS clinicians have given rise to a shift in EMS strategies in many countries. From transport to the emergency department to at the scene deciding on the most appropriate level of care and mode of transport. Among the non-conveyed patients some may suffer from "time-sensitive conditions" delaying diagnosis and treatment. Thus, four questions arise: 1) How often are time-sensitive cases referred to primary care or self-care advice? 2) How can we measure and define the level of inappropriate clinical decision-making? 3) What is acceptable? 4) How to increase patient safety? To what extent time-sensitive cases are non-conveyed varies. About 5-25% of referred patients visit the emergency department within 72 hours, 5% are hospitalised, 1-3% are reported to have a time-sensitive condition and seven-day mortality rates range from 0.3 to 6%. The level of inappropriate clinical decision-making can be measured using surrogate measures such as emergency department attendances, hospitalisation and short-term mortality. These measures do not reveal time-sensitive conditions. Defining a scoring system may be one alternative, where misclassifications of time-sensitive cases are rated based on how severely they affected patient outcome. In terms of what is acceptable there is no general agreement. Although a zero-vision approach does not seem to be realistic unless under-triage is split into different levels of severity with zero-vision in the most severe categories. There are several ways to reduce the risk of misclassifications. Implementation of support systems for decision-making using machine learning to improve the initial assessment is one approach. Using a trigger tool to identify adverse events is another. A substantial number of patients are non-conveyed, including a small portion with time-sensitive conditions. This poses a threat to patient safety. No general agreement on how to define and measure the extent of such EMS referrals and no agreement of what is acceptable exists, but we conclude an overall zero-vision is not realistic. Developing specific tools supporting decision making regarding EMS referral may be one way to reduce misclassification rates.

Sections du résumé

BACKGROUND
The emergency medical services (EMS) have undergone dramatic changes during the past few decades. Increased utilisation, changes in care-seeking behaviour and competence among EMS clinicians have given rise to a shift in EMS strategies in many countries. From transport to the emergency department to at the scene deciding on the most appropriate level of care and mode of transport. Among the non-conveyed patients some may suffer from "time-sensitive conditions" delaying diagnosis and treatment. Thus, four questions arise: 1) How often are time-sensitive cases referred to primary care or self-care advice? 2) How can we measure and define the level of inappropriate clinical decision-making? 3) What is acceptable? 4) How to increase patient safety?
MAIN TEXT
To what extent time-sensitive cases are non-conveyed varies. About 5-25% of referred patients visit the emergency department within 72 hours, 5% are hospitalised, 1-3% are reported to have a time-sensitive condition and seven-day mortality rates range from 0.3 to 6%. The level of inappropriate clinical decision-making can be measured using surrogate measures such as emergency department attendances, hospitalisation and short-term mortality. These measures do not reveal time-sensitive conditions. Defining a scoring system may be one alternative, where misclassifications of time-sensitive cases are rated based on how severely they affected patient outcome. In terms of what is acceptable there is no general agreement. Although a zero-vision approach does not seem to be realistic unless under-triage is split into different levels of severity with zero-vision in the most severe categories. There are several ways to reduce the risk of misclassifications. Implementation of support systems for decision-making using machine learning to improve the initial assessment is one approach. Using a trigger tool to identify adverse events is another.
CONCLUSION
A substantial number of patients are non-conveyed, including a small portion with time-sensitive conditions. This poses a threat to patient safety. No general agreement on how to define and measure the extent of such EMS referrals and no agreement of what is acceptable exists, but we conclude an overall zero-vision is not realistic. Developing specific tools supporting decision making regarding EMS referral may be one way to reduce misclassification rates.

Identifiants

pubmed: 35606694
doi: 10.1186/s12873-022-00643-3
pii: 10.1186/s12873-022-00643-3
pmc: PMC9125920
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

89

Informations de copyright

© 2022. The Author(s).

Références

Brain Behav. 2019 May;9(5):e01266
pubmed: 30980519
J Patient Saf. 2010 Dec;6(4):247-50
pubmed: 21500613
CMAJ. 2004 Jun 8;170(12):1803-7
pubmed: 15184334
BMC Emerg Med. 2020 Aug 10;20(1):61
pubmed: 32778074
BMC Emerg Med. 2020 Jan 30;20(1):7
pubmed: 32000684
PLoS One. 2014 Nov 07;9(11):e112282
pubmed: 25379675
Acad Emerg Med. 2002 Jul;9(7):671-8
pubmed: 12093706
Diagnosis (Berl). 2020 Mar 19;8(2):193-198
pubmed: 32191624
Ann Emerg Med. 2001 Sep;38(3):268-77
pubmed: 11524646
Diagnosis (Berl). 2021 Apr 26;8(4):479-488
pubmed: 33894108
Neurology. 2017 Apr 11;88(15):1468-1477
pubmed: 28356464
Int Emerg Nurs. 2019 Sep;46:100778
pubmed: 31331836
BMJ Open. 2021 Apr 15;11(4):e044938
pubmed: 33858871
Nurs Open. 2019 Mar 19;6(3):783-789
pubmed: 31367400
Prehosp Emerg Care. 2004 Apr-Jun;8(2):116-25
pubmed: 15060844
Crit Pathw Cardiol. 2021 Sep 1;20(3):155-162
pubmed: 33606411
BMJ Open. 2020 Jul 14;10(7):e036659
pubmed: 32665389
J Gen Intern Med. 2006 Nov;21(11):1192-4
pubmed: 17026729
F1000Res. 2017 Oct 2;6:1791
pubmed: 29043079
J Emerg Med. 2011 Jun;40(6):623-8
pubmed: 18930373
Prehosp Disaster Med. 1999 Jul-Sep;14(3):174-9
pubmed: 10724742
Prehosp Emerg Care. 2009 Oct-Dec;13(4):516-27
pubmed: 19731166
Int Emerg Nurs. 2016 May;26:32-7
pubmed: 26472522
Scand J Trauma Resusc Emerg Med. 2017 Jul 17;25(1):71
pubmed: 28716132
N Engl J Med. 2018 Mar 15;378(11):981-983
pubmed: 29539284
Ann Emerg Med. 2013 Jun;61(6):605-611.e6
pubmed: 23218508
Qual Health Care. 1999 Dec;8(4):234-8
pubmed: 10847885
BMJ Qual Saf. 2014 Aug;23(8):670-7
pubmed: 24764136
N Engl J Med. 2000 Apr 20;342(16):1163-70
pubmed: 10770981
BMJ Qual Saf. 2016 Feb;25(2):71-5
pubmed: 26347519
PLoS One. 2021 May 13;16(5):e0251686
pubmed: 33984054
Int Emerg Nurs. 2017 May;32:45-49
pubmed: 28291697
Scand J Trauma Resusc Emerg Med. 2020 May 29;28(1):45
pubmed: 32471460
Coron Artery Dis. 2021 Jun 1;32(4):345-349
pubmed: 33196583
Prehosp Emerg Care. 2016 Jul-Aug;20(4):539-49
pubmed: 26836060
Ann Emerg Med. 2007 Feb;49(2):196-205
pubmed: 16997424
Acad Emerg Med. 2021 Feb;28(2):184-196
pubmed: 33277724
BMJ Open. 2018 Nov 28;8(11):e024228
pubmed: 30498049
Acta Neurol Scand. 2021 Mar;143(3):318-325
pubmed: 33141437
PLoS One. 2019 Dec 13;14(12):e0226518
pubmed: 31834920
J Accid Emerg Med. 1996 Jul;13(4):256-7
pubmed: 8832343
Scand J Trauma Resusc Emerg Med. 2020 Jul 29;28(1):74
pubmed: 32727586
Scand J Trauma Resusc Emerg Med. 2020 Mar 4;28(1):17
pubmed: 32131867
N Engl J Med. 2003 Mar 13;348(11):1051-6
pubmed: 12637617
Prehosp Emerg Care. 2012 Jan-Mar;16(1):20-35
pubmed: 22128905
Arch Acad Emerg Med. 2019 Aug 28;7(1):e52
pubmed: 31602435
Health Aff (Millwood). 2011 Apr;30(4):581-9
pubmed: 21471476
PLoS One. 2021 Mar 10;16(3):e0247881
pubmed: 33690653

Auteurs

Carl Magnusson (C)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, SE-405 30, Gothenburg, Sweden. carl.magnusson@vgregion.se.
Department of Prehospital Emergency Care , Sahlgrenska University Hospital, SE-411 04, Gothenburg, Sweden. carl.magnusson@vgregion.se.

Magnus Andersson Hagiwara (MA)

Prehospen-Centre for Prehospital Research, Faculty of Caring Science, Work Life and Social Welfare, University of Borås, SE-501 90, Borås, Sweden.

Gabriella Norberg-Boysen (G)

Prehospen-Centre for Prehospital Research, Faculty of Caring Science, Work Life and Social Welfare, University of Borås, SE-501 90, Borås, Sweden.

Wivica Kauppi (W)

Prehospen-Centre for Prehospital Research, Faculty of Caring Science, Work Life and Social Welfare, University of Borås, SE-501 90, Borås, Sweden.

Johan Herlitz (J)

Prehospen-Centre for Prehospital Research, Faculty of Caring Science, Work Life and Social Welfare, University of Borås, SE-501 90, Borås, Sweden.

Christer Axelsson (C)

Department of Prehospital Emergency Care , Sahlgrenska University Hospital, SE-411 04, Gothenburg, Sweden.
Prehospen-Centre for Prehospital Research, Faculty of Caring Science, Work Life and Social Welfare, University of Borås, SE-501 90, Borås, Sweden.

Niclas Packendorff (N)

Prehospen-Centre for Prehospital Research, Faculty of Caring Science, Work Life and Social Welfare, University of Borås, SE-501 90, Borås, Sweden.

Glenn Larsson (G)

Prehospen-Centre for Prehospital Research, Faculty of Caring Science, Work Life and Social Welfare, University of Borås, SE-501 90, Borås, Sweden.

Kristoffer Wibring (K)

Department of Ambulance and Prehospital Care, Region Halland, SE-302 49, Halmstad, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH